VivoSeq
Other

Bismuth Quadruple Therapy

0

Pipeline Programs↗

2

Active Trials↗

1

Companies Involved↗

Bismuth Quadruple Therapy is an early-stage landscape with 0 programs across 1 company. The most active players are Shandong Luoxin Pharmaceutical Group Stock Co., Ltd..

Intelligence

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

S

Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

15

clinical trials

Unknown status7 · 47%
Completed6 · 40%
Recruiting2 · 13%

Clinical Trials

Trial Activity

15 trials

Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy and Bismuth Quadruple Therapy
Recruiting·KKaohsiung Medical University·N/A·NCT07358130·552 enrolled
Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment
Recruiting·—·Phase 4·NCT07139366·1,248 enrolled
Comparison of 7-day PPI-based Standard Triple Therapy and 10-day Bismuth Quadruple Therapy for H. Pylori Eradication
Completed·National Cancer Center, Korea·Phase 3·NCT02557932·352 enrolled
Efficacy and Safety of Tegoprazan Versus Esomeprazole-containing Bismuth Quadruple Therapy for Eradication of Helicobacter Pylori
Completed·SShandong Luoxin Pharmaceutical Group Stock Co., Ltd.·Phase 3·NCT05577468·561 enrolled
Susceptibility-guided Bismuth Quadruple Therapy for Multiple-resistant Helicobacter Pylori Strains
Completed·NNational Cheng-Kung University Hospital·Phase 4·NCT06687473·13 enrolled
Comparing the Efficacy of Reverse Hybrid Therapy and Bismuth Quadruple Therapy
Completed·KKaohsiung Veterans General Hospital.·N/A·NCT02547038·352 enrolled
Tegoprazan-Amoxicillin Dual Therapy vs. Bismuth Quadruple Therapy for H. Pylori Infection (TATH-1)
Completed·ZZhang Xiaofeng,MD·Phase 4·NCT05647278·370 enrolled
14-day Susceptibility-guided Bismuth Quadruple Therapy for Multiple Drug Resistant H. Pylori Infection
Completed·NNational Cheng-Kung University Hospital·Phase 4·NCT06687499·46 enrolled
Study on the Efficacy and Safety of Berberine, Minocycline, Esomeprazole, and Colloidal Bismuth Quadruple Therapy in the Initial Treatment of Helicobacter Pylori.
Unknown status·XXijing Hospital of Digestive Diseases·Phase 4·NCT06603688·548 enrolled
Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Therapy of Different Tetracycline Doses and Frequencies.
Unknown status·SShandong University·Phase 4·NCT05432115·407 enrolled
Efficacy and Safety of Bismuth Quadruple Therapy Containing Cefuroxime and Tetracycline as First-line Therapy for Eradicating Helicobacter Pylori in Patients Allergic to Penicillin
Unknown status·QQilu Hospital of Shandong University·Phase 4·NCT06351891·248 enrolled
Vonoprazan-containing Triple Therapy Versus Empiric Bismuth Quadruple Therapy for First-line Helicobacter Pylori Treatment: a Randomized Clinical Trial
Unknown status·SShanghai East Hospital·Phase 4·NCT05726734·100 enrolled
A Comparison of High-dose Dual Therapy and Half-dose Clarithromycin-containing Bismuth Quadruple Therapy for H.P Eradication in Elderly Patients
Unknown status·SShandong University·Phase 4·NCT04101708·100 enrolled
Bismuth Quadruple Therapy in Helicobacter Pylori Rescue Therapy of Different Tetracycline Doses and Frequencies.
Unknown status·SShandong University·Phase 4·NCT05802888·260 enrolled
Bismuth Quadruple Therapy Versus Standard Triple Therapy
Unknown status·UUniversity Medical Centre Ljubljana·Phase 4·NCT06143124·216 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)